← Browse by Condition
Medical Condition

cirrhosis

Total Trials
16
Recruiting Now
16
Trial Phases
Phase 4, Phase 2

ClinicalMetric tracks all active clinical trials for cirrhosis sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — cirrhosis Clinical Trials

How many clinical trials are currently recruiting for cirrhosis?
ClinicalMetric currently tracks 16 actively recruiting clinical trials for cirrhosis, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 16. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for cirrhosis?
cirrhosis research spans Phase 2 (2 trials), Phase 4 (3 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a cirrhosis clinical trial?
Eligibility criteria for cirrhosis trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
2
Phase 4
3
Top Sponsors
Mayo Clinic 2 trials
Hospices Civils de Lyon 2 trials
The First Affiliated Hospital of University of South China 1 trial
Central Hospital, Nancy, France 1 trial
Tanta University 1 trial

Recruiting Clinical Trials

NCT07147335
Recruiting
The Role of Serum AKR1B10 in Early Warning of Hepatocellular Carcinoma in Cirrhosis Patients
Enrollment
800 pts
Location
China
Sponsor
The First Affiliated Hospital ...
View Trial →
NCT06778317
Recruiting
mSEPT9 Biomarker for Predicting Hepatocellular Carcinoma Occurrence in Patients With Cirrhosis
Enrollment
400 pts
Location
France
Sponsor
Central Hospital, Nancy, Franc...
View Trial →
NCT06881628 Phase 4
Recruiting
Tranxemic Acid and Vitamin K Injection to Control Upper Gastrointestinal Bleeding in Cirrhotic Patients
Enrollment
194 pts
Location
Egypt
Sponsor
Tanta University
View Trial →
NCT06306963
Recruiting
Prevalence of Gastric Motor Dysfunction and Upper GI Symptoms in Gastric Antral Vascular Ectasias
Enrollment
30 pts
Location
United States
Sponsor
Mayo Clinic
View Trial →
NCT06911619
Recruiting
Impact of Nutritional Management on the Frailty of Patients Waiting for Liver Transplantation (Via the LFI Tool)
Enrollment
210 pts
Location
France
Sponsor
Hospices Civils de Lyon
View Trial →
NCT07462091
Recruiting
Vagus Nerve-guided Laparoscopic Splenectomy and Azygoportal Disconnection
Enrollment
15 pts
Location
China
Sponsor
Northern Jiangsu People's Hosp...
View Trial →
NCT03506893
Recruiting
Medical-economic Evaluation of the Care of Refractory Ascites by Implantation of Alfapump® Device in Cirrhotic Patients
Enrollment
90 pts
Location
France
Sponsor
University Hospital, Grenoble
View Trial →
NCT06425380
Recruiting
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
Enrollment
11 pts
Location
United States
Sponsor
Mayo Clinic
View Trial →
NCT07046429
Recruiting
Affect of Melatonin on Sleep and Cognition in Cirrhosis
Enrollment
18 pts
Location
United States
Sponsor
Weill Medical College of Corne...
View Trial →
NCT06687265 Phase 2
Recruiting
Effects of Metformin on Hepatic Venous Pressure Gradient in Patients With Cirrhosis and Portal Hypertension
Enrollment
76 pts
Location
France
Sponsor
Assistance Publique - Hôpitaux...
View Trial →
NCT06594783 Phase 4
Recruiting
Carvedilol Plus EVL or Not for the Primary Prevention of Esophageal Variceal Bleeding in Carvedilol Non-responders
Enrollment
80 pts
Location
Taiwan
Sponsor
Taipei Veterans General Hospit...
View Trial →
NCT05486572
Recruiting
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
Enrollment
4,700 pts
Location
United States
Sponsor
VA Office of Research and Deve...
View Trial →
NCT03225677
Recruiting
Novel Tracer Methods to Evaluate Muscle Protein Metabolism in Cirrhosis
Enrollment
20 pts
Location
United States
Sponsor
The Cleveland Clinic
View Trial →
NCT07521332 Phase 4
Recruiting
Apixaban-PK Trial: Preventing Portal Hypertension Complications in Cirrhosis
Enrollment
220 pts
Location
Pakistan
Sponsor
Asian Institute Of Medical Sci...
View Trial →
NCT06937307 Phase 2
Recruiting
Droxidopa to Increase Mean Arterial Pressure in Decompensated Cirrhosis Patients With Acute Kidney Injury
Enrollment
75 pts
Location
United States
Sponsor
Giuseppe Cullaro, MD
View Trial →
NCT06307964
Recruiting
Intra-Hepatic Microbiota in Alcoholic Hepatitis
Enrollment
50 pts
Location
France
Sponsor
Hospices Civils de Lyon
View Trial →

Related Conditions

hepatic encephalopathy (3) ascites (2) hepotacellular carcinoma (1) hepatocellular carcinoma hcc (1) risk prediction for liver cancer (1) epigenomics (1) upper gastrointestinal bleeding ugib (1) variceal bleeding (1) gastric antral vascular ectasia (1) chronic kidney disease (1) fragility (1) hepatic transplantation (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology